Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMAIN: Rituximab and HD-MTX Combination for Elderly PCNSL
NCT00989352Phase 2Unknown
- Sponsor
- University Hospital Freiburg
- Start
- Sep 2009
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab, methotrexate, lomustine, procarbazine in primary central nervous system lymphoma (PCNSL), sponsored by University Hospital Freiburg. Status: unknown.
02
Drugs
rituximabmethotrexatelomustineprocarbazine
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00989352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989352.